Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2018 1
2019 1
2020 1
2021 5
2022 4
2023 5
2024 4

Text availability

Article attribute

Article type

Publication date

Search Results

18 results

Results by year

Filters applied: . Clear all
Page 1
Effects of baricitinib, empagliflozin, linagliptin and telmisartan on cardiovascular autonomic neuropathy in type 1 diabetes: An exploratory, randomized, open-label, crossover trial.
Laursen JC, Rotbain Curovic V, Kroonen MYAM, Jongs N, Zobel EH, Hansen TW, Frimodt-Møller M, Laverman GD, Kooy A, Persson F, Heerspink HJL, Hansen CS, Rossing P. Laursen JC, et al. Among authors: rotbain curovic v. Diabetes Obes Metab. 2023 Oct;25(10):3064-3067. doi: 10.1111/dom.15180. Epub 2023 Jun 29. Diabetes Obes Metab. 2023. PMID: 37385968 Clinical Trial. No abstract available.
Overall and inter-individual effect of four different drug classes on soluble urokinase plasminogen activator receptor in type 1 and type 2 diabetes.
Rotbain Curovic V, Houlind MB, Kroonen MYAM, Jongs N, Zobel EH, Hansen TW, Tavenier J, Eugen-Olsen J, Laverman GD, Kooy A, Persson F, Rossing P, Heerspink HJL. Rotbain Curovic V, et al. Diabetes Obes Metab. 2023 Nov;25(11):3152-3160. doi: 10.1111/dom.15209. Epub 2023 Jul 7. Diabetes Obes Metab. 2023. PMID: 37417375 Clinical Trial.
Presence of retinopathy and incident kidney and cardiovascular events in type 2 diabetes with normoalbuminuria - A post-hoc analysis of the PRIORITY randomized clinical trial.
Rotbain Curovic V, Tofte N, Lindhardt M, Adamova K, Bakker SJL, Beige J, Beulens JWJ, Birkenfeld AL, Currie G, Delles C, Dimos I, Francová L, Frimodt-Møller M, Girman P, Göke R, Hansen TW, Havrdova T, Kooy A, Laverman GD, Mischak H, Navis G, Nijpels G, Noutsou M, Ortiz A, Parvanova A, Persson F, Petrie JR, Ruggenenti PL, Rutters F, Rychlík I, Siwy J, Spasovski G, Speeckaert M, Trillini M, Zürbig P, von der Leyen H, Rossing P; on the behalf of the PRIORITY Study Group. Rotbain Curovic V, et al. J Diabetes Complications. 2023 Apr;37(4):108433. doi: 10.1016/j.jdiacomp.2023.108433. Epub 2023 Feb 18. J Diabetes Complications. 2023. PMID: 36841085 Clinical Trial.
Effect of liraglutide on expression of inflammatory genes in type 2 diabetes.
Zobel EH, Ripa RS, von Scholten BJ, Rotbain Curovic V, Kjaer A, Hansen TW, Rossing P, Størling J. Zobel EH, et al. Among authors: rotbain curovic v. Sci Rep. 2021 Sep 17;11(1):18522. doi: 10.1038/s41598-021-97967-0. Sci Rep. 2021. PMID: 34535716 Free PMC article. Clinical Trial.
The effect of liraglutide on cardiac autonomic function in type 2 diabetes: A prespecified secondary analysis from the LIRAFLAME randomized, double-blinded, placebo-controlled trial.
Sivalingam S, Hein Zobel E, Hansen CS, Ripa RS, von Scholten BJ, Rotbain Curovic V, Kjaer A, Jensen JK, Hansen TW, Rossing P. Sivalingam S, et al. Among authors: rotbain curovic v. Diabetes Obes Metab. 2022 Aug;24(8):1638-1642. doi: 10.1111/dom.14717. Epub 2022 May 12. Diabetes Obes Metab. 2022. PMID: 35415938 Clinical Trial. No abstract available.
Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetes.
Ferreira-Divino LF, Suvitaival T, Rotbain Curovic V, Tofte N, Trošt K, Mattila IM, Theilade S, Winther SA, Hansen TW, Frimodt-Møller M, Legido-Quigley C, Rossing P. Ferreira-Divino LF, et al. Among authors: rotbain curovic v. Cardiovasc Diabetol. 2022 Jul 18;21(1):135. doi: 10.1186/s12933-022-01568-8. Cardiovasc Diabetol. 2022. PMID: 35850688 Free PMC article.
Ceramides and phospholipids are downregulated with liraglutide treatment: results from the LiraFlame randomized controlled trial.
Zobel EH, Wretlind A, Ripa RS, Rotbain Curovic V, von Scholten BJ, Suvitaival T, Hansen TW, Kjær A, Legido-Quigley C, Rossing P. Zobel EH, et al. Among authors: rotbain curovic v. BMJ Open Diabetes Res Care. 2021 Sep;9(1):e002395. doi: 10.1136/bmjdrc-2021-002395. BMJ Open Diabetes Res Care. 2021. PMID: 34518158 Free PMC article. Clinical Trial.
18 results